Publications du CNR en 2019

Andrés, M., Werf, M. J. van der, Ködmön, C., Albrecht, S., Haas, W., Fiebig, L. and Group, S. study (2019). Molecular and genomic typing for tuberculosis surveillance: A survey study in 26 European countries. PLOS ONE 14, e0210080, http://doi.org/10.1371/journal.pone.0210080.

Aubry, A. and Veziris, N. (2019). Smear Microscopy Complements Xpert MTB/RIF When Considering Nontuberculous Mycobacterial Infections. Am J Respir Crit Care Med 200, 1072–1073, http://doi.org/10.1164/rccm.201905-0965LE.

Baron, V., Forfait, C., Colot, J., Carzola, C., Descloux, E., Cauchoix, B., Cambau, E., Gaumery, J., Grangeon, J. and Klement, E. (2019). Épidémiologie de la lèpre en Nouvelle-Calédonie de 1983 à 2017. BEH 400–405, URL: https://www.santepubliquefrance.fr/import/epidemiologie-de-la-lepre-en-nouvelle-caledonie-de-1983-a-2017 [Accessed February 2022].

Bouziane, F., Allem, R., Sebaihia, M., Kumanski, S., Mougari, F., Sougakoff, W., Raskine, L., Yala, D. and Cambau, E. (2019). First genetic characterisation of multidrug-resistant Mycobacterium tuberculosis isolates from Algeria. Journal of Global Antimicrobial Resistance 19, 301–307, http://doi.org/10.1016/j.jgar.2019.05.010.

Daniau, C., Lecorché, E., Mougari, F. and et al. (2019). Infections invasives à Mycobacterium chimaera en chirurgie cardiaque et évaluation des pratiques autour des matériels de circulation extracorporelle. Hygienes 27, 351–359, http://doi.org/10.25329/hy_xxvii_6-1.

Decalonne, M., Lecorche, E., Hau, E., Petiteau, A., Moreau, C., Milan, O., Lanotte, P., Mereghetti, L., Cambau, E. and van der Mee-Marquet, N. (2019). Cause Analysis of an Infection in Facelift Surgery Due to Mycobacterium chelonae. Frontiers in Medicine 6, URL: https://www.frontiersin.org/article/10.3389/fmed.2019.00243 [Accessed February 2022].

Dutertre, M., Delobel, P., Marchou, B., Boyer, J.-F., Mougari, F. and Martin-Blondel, G. (2019). Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritis. Médecine et Maladies Infectieuses 49, 358–359, http://doi.org/10.1016/j.medmal.2019.03.002.

Guglielmetti, L., Jaffré, J., Bernard, C., Brossier, F., El Helali, N., Chadelat, K., Thouvenin, G., Dautzenberg, B., Henry, B., Jaspard, M., Guillot, H., Pourcher, V., Le Dû, D., Marigot-Outtandy, D., Mougari, F., Raskine, L., Rivoire, B., Andrejak, C., Jarlier, V., Aubry, A., Robert, J., Frechet-Jachym, M. and Veziris, N. (2019). Multidisciplinary advisory teams to manage multidrug-resistant tuberculosis: the example of the French Consilium. The International Journal of Tuberculosis and Lung Disease 23, 1050–1054, http://doi.org/10.5588/ijtld.18.0779.

Guglielmetti, L., Sougakoff, W., Maitre, T., Brossier, F., Jarlier, V., Robert, J., Veziris, N. and Aubry, A. (2019). Poor Performance of Rapid Molecular Tests to Define Eligibility for the Shortcourse Multidrug-resistant Tuberculosis Regimen. Clinical Infectious Diseases 68, 1410–1411, http://doi.org/10.1093/cid/ciy808.

Mbuagbaw, L., Guglielmetti, L., Hewison, C., Bakare, N., Bastard, M., Caumes, E., Fréchet-Jachym, M., Robert, J., Veziris, N., Khachatryan, N., Kotrikadze, T., Hayrapetyan, A., Avaliani, Z., Schünemann, H. J. and Lienhardt, C. (2019). Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis. Emerg Infect Dis 25, http://doi.org/10.3201/eid2505.181823.

Perrineau, S., Lachâtre, M., Lê, M. P., Rioux, C., Loubet, P., Fréchet-Jachym, M., Gonzales, M. C., Grall, N., Bouvet, E., Veziris, N., Yazdanpanah, Y. and Peytavin, G. (2019). Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis. Int J Tuberc Lung Dis 23, 99–104, http://doi.org/10.5588/ijtld.18.0042.

Petrella, S., Capton, E., Raynal, B., Giffard, C., Thureau, A., Bonneté, F., Alzari, P. M., Aubry, A. and Mayer, C. (2019). Overall Structures of Mycobacterium tuberculosis DNA Gyrase Reveal the Role of a Corynebacteriales GyrB-Specific Insert in ATPase Activity. Structure 27, 579-589.e5, http://doi.org/10.1016/j.str.2019.01.004.

Rodriguez, C. A., Brooks, M. B., Guglielmetti, L., Hewison, C., Jachym, M. F., Lessem, E., Varaine, F. and Mitnick, C. D. (2019). Barriers and facilitators to early access of bedaquiline and delamanid for MDR-TB: a mixed-methods study. Public Health Action 9, 32–41, http://doi.org/10.5588/pha.18.0078.

Rollet-Cohen, V., Roux, A.-L., Bourgeois, M. L., Sapriel, G., Bahri, M. E., Jais, J.-P., Heym, B., Mougari, F., Raskine, L., Véziris, N., Gaillard, J.-L. and Sermet-Gaudelus, I. (2019). Mycobacterium bolletii lung disease in cystic fibrosis. CHEST 0, http://doi.org/10.1016/j.chest.2019.03.019.

Sane Schepisi, M., Navarra, A., Altet Gomez, M. N., Dudnyk, A., Dyrhol-Riise, A. M., Esteban, J., Giorgetti, P. F., Gualano, G., Guglielmetti, L., Heyckendorf, J., Kaluzhenina, A., Lange, B., Lange, C., Manika, K., Miah, J., Nanovic, Z., Pontali, E., Prego, M. R., Solovic, I., Tiberi, S., Palmieri, F. and Girardi, E. (2019). Burden and Characteristics of the Comorbidity Tuberculosis—Diabetes in Europe: TBnet Prevalence Survey and Case-Control Study. Open Forum Infectious Diseases 6, ofy337, http://doi.org/10.1093/ofid/ofy337.

van Leth, F., Brinkmann, F., Cirillo, D. M., Dheda, K., Duarte, R., Guglielmetti, L., Kuksa, L., Lange, C., Mitnick, C., Skrahina, A., Zaman, K. and Bothamley, G. (2019). The Tuberculosis Network European Trials group (TBnet) ERS Clinical Research Collaboration: addressing drug-resistant tuberculosis through European cooperation. European Respiratory Journal 53, http://doi.org/10.1183/13993003.02089-2018.